Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-14 5:06 pm Sale | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Versant Ventures IV LLC | 500,387 2.400% | -4,503,505 (-90.00%) | View |
| 2021-02-16 07:33 am Purchase | 13D | CRISPR Therapeutics AG CRSP | Versant Ventures IV LLC | 1,344,010 1.900% | 1,344,010 (New Position) | View |
| 2020-12-23 5:17 pm Sale | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Versant Ventures IV LLC | 5,003,892 5.100% | -2,000,000 (-28.56%) | View |